secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001213900-25-059702
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix closes $85M public offering of common stock, net proceeds $82.2M
-------------------------------------------------------------------------

- Closed public offering of 6,604,507 shares at gross proceeds ~$85M.
- Net proceeds ~$82.2M; could reach ~$94.8M if underwriters' option exercised in full.
- Underwriters have a 30-day option to purchase up to 990,676 additional shares.
- Proceeds to be used for general corporate purposes, including R&D and strategic transactions.
- RBC Capital Markets acted as sole bookrunner; Truist, Citizens, Needham as advisors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390025059702/0001213900-25-059702-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390025059702/ea0247458-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059702

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer